Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Ovarian Neoplasms × cediranib × Clear all

Phase

Phase 2 4 Phase 3 3 Phase 1 3 Phase NA 1 Phase EARLY_PHASE1 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1

Interventions

olaparib 4 Specimen Handling 4 Magnetic Resonance Spectroscopy 4 Cyclophosphamide 4 fludarabine 3 X-Rays 2 Taxes 2 Platinum 2 Paclitaxel 2 Oncolytic Virotherapy 2 Letrozole 2 Hyperthermic Intraperitoneal Chemotherapy 2 Fluorodeoxyglucose F18 2 Doxorubicin 2 Cytoreduction Surgical Procedures 2 Cisplatin 2 Carboplatin 2 Aspirin 2 1,2-diaminocyclohexaneplatinum II citrate 2 trastuzumab biosimilar HLX02 1 sodium thiosulfate 1 pertuzumab 1 pembrolizumab 1 palbociclib 1 niraparib 1 montelukast 1 gallium 68 PSMA-11 1 eribulin 1 entrectinib 1 cobimetinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02855697 2022-02-22

MOLTO

The Christie NHS Foundation Trust

Phase EARLY_PHASE1 Completed

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡